Successful Management of Osimertinib-Induced Heart Failure

Successful Management of Osimertinib-Induced Heart Failure

Cancer therapeutics-related cardiac dysfunction is currently of great concern as one of the pivotal therapeutic targets of onco-cardiology. Only a few studies have reported the occurrence of heart failure following the administration of osimertinib, a third-generation epidermal growth factor recepto...

Full description

Bibliographic Details
Main Authors: Atsuko Fukuo, Teruhiko Imamura, Hiroshi Onoda, Koichiro Kinugawa
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Medicina
Subjects:
heart failure
cancer
onco-cardiology
Online Access:https://www.mdpi.com/1648-9144/58/2/312

Similar Items

Similar Items